🇺🇸 FDA
Patent

US 10633445

T-cell receptor (TCR)-binding antibodies and uses thereof

granted A61KA61K39/39558A61P

Quick answer

US patent 10633445 (T-cell receptor (TCR)-binding antibodies and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K39/39558, A61P, A61P35/02, A61P37/06